Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 3-Nitrosalicylic acid | HCID 6807 | — |
| Edukt | Thionyl Chloride | HCID 24386 | — |
| Edukt | Sulfur | HCID 5362487 | — |
| Edukt | 2-Hydroxy-3-nitrobenzamide | HCID 11275392 | — |
| Katalysator | Nickel | HCID 935 | — |
| Katalysator | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Katalysator | Palladium | HCID 23938 | — |
| Lösungsmittel | Triethylamine | HCID 8471 | — |
| Produkt | 3-Aminosalicylamide | HCID 11378596 | — |
Reaktionsschritte
A preferred synthesis of the desired product acylated aminosalicylamides (Formula I) is shown in the following Scheme 1. 2-Hydroxy-3-nitrobenzoic acid 1 was converted to the acid chloride 2 with excess thionyl chloride. After removal of the excess thionyl chloride, the crude acid chloride 2 was reacted with the desired cyclic amine 3 in dichloromethane solution containing triethylamine as an acid scavenger and 4-dimethylaminopyridine (DMAP) as a catalyst. Crude 3-nitrosalicylamide 4 could be isolated after washing the reaction mixture with dilute HCl solution, drying, and evaporation of the solvent. Usually 4 was of sufficient purity to carry forward to the final product 6, but if desired could be purified by recrystallization or chromatography or a combination of both. In some cases where the 3-nitrosalicylamide 4 is a mixture of diastereomers, one might choose to isolate the individual diastereomers at this stage. However, since all of the various diastereomers are fuigicidally active, this is not necessary. The 3-nitrosalicylamide (4) was subsequently reduced under catalytic hydrogenation conditions using Pd, Pt, or Ni catalysts either unpoisoned or poisoned with sulfur or lead. The 3-aminosalicylamide 5 usually was not isolated, but immediately reacted with excess acetic-formic anhydride. Isolation of the AASA product 6 was a simple matter of filtration, washing with sodium bicarbonate solution, drying and evaporation of the solvent The crude product 6, usually a solid foam or glass, often was of sufficient purity to be directly submitted for testing. However, if desired, it could be further purified by recrystallization or chromatography or a combination of both.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06297401B1 |
|---|
| Quelldatensatz | uspto-grants-2001_10 |
|---|
| ORD ID | ord-97bbca9c62ef4e11a7eb3d947be86904 |
|---|
| Quellennotiz | uspto-grants-2001_10 |
|---|